The present study aims at preparing an Emulgel formulation of Meloxicam using emulsifiers and various gelling agents along with the use of. PDF | Emulgel is one of the recent technologies in NDDS used for dual control release of emulsion and gel for topical use. The stability of. PDF | Topical therapies in cream, ointment, gel and lotion formulation, are an important component of dermatological therapeutic.

Author: Kagalabar Kinos
Country: Moldova, Republic of
Language: English (Spanish)
Genre: Medical
Published (Last): 6 March 2006
Pages: 478
PDF File Size: 2.85 Mb
ePub File Size: 13.87 Mb
ISBN: 165-4-41884-711-5
Downloads: 39404
Price: Free* [*Free Regsitration Required]
Uploader: Kajisida

The Pharmaceutical Press; Support Center Support Center. Received Dec formulatiom Accepted May Swarbrick J, Boylan JC, editors. Commercially available CHL topical powder was used for comparison.

Optimization of chlorphenesin emulgel formulation

Development of a thermoreversible gel for controlled-release ocular delivery of diclofenac sodium. The influence of the type of the gelling agent and the concentration of both the oil phase and emulsifying agent on the drug release from the prepared emulgels was investigated using a 2 3 factorial design.

Author information Article notes Copyright and License information Disclaimer. Stability studies showed that the physical appearance, rheological properties, drug release, and antifungal activity in all the prepared emulgels remained unchanged upon storage for 3 months.


Optimization of chlorphenesin emulgel formulation

Az J Pharm Sci. This study was conducted to develop an emulgel formulation of chlorphenesin CHL using 2 types of gelling agents: Lea and Febiger; Blackwell Scientific Publications; Abstract This study was conducted to develop an emulgel formulahion of chlorphenesin CHL using 2 types of gelling agents: As a general conclusion, it was suggested that the CHL emulgel formulation prepared with HPMC with the oil phase concentration in its low level and emulsifying agent concentration in its high level was emmulgel formula of choice since it showed the highest drug release and antifungal activity.

The drug emulgrl from all the emulgels was found to follow diffusion-controlled mechanism. The prepared emulgels were evaluated for their physical appearance, rheological behavior, drug release, antifungal activity, and stability.

Preparation of an emulgel for treatment of aphthous ulcer on the basis of carbomers. Analysis of data on the medicament release from ointments. Formulation and stability of chloramphenicol gel and emulgel. Transdermal controlled release systems.

Published online Sep 1. This article has been cited by other articles in PMC. Rheological studies revealed that the CHL emulgels exhibited a shear-thinning behavior with thixotropy.


Medical Applications of Controlled Release. Marcel Dekker Inc; The Theory and Practice of Industrial Pharmacy. They also formlation higher drug release and antifungal activity than the CHL powder.

Encyclopedia of Pharmaceutical Technology.

There was a problem providing the content you requested

Formulation and formu,ation of topical preparations containing phenol and local vesicants. All the prepared emulgels showed acceptable physical properties concerning color, homogeneity, consistency, spreadability, and pH value. A study of shear and compression deformations on hydrophilic gels of tretinoin.

Please review our privacy policy. National Center for Biotechnology InformationU. The Complete Drug Reference.

It was found that the emulsifying agent concentration had formulaton most pronounced effect on the drug release from the emulgels followed by the oil phase concentration and finally the type of the gelling agent.

Bioavailability of salbutamol sulphate from different suppository formulations.

Egypt J Pharm Sci.